A new opinion article featuring CADRE investigator Lauren Micalizzi examines how evolving cannabis policy may affect policies related to cannabis use during pregnancy.
New research examines trends in the co-use of nicotine/tobacco products, alcohol, and cannabis across youth and adult populations in the United States. Using data from the Population Assessment of Tobacco and Health (PATH) Study, the study highlights how patterns of polysubstance use vary across age groups and evolve alongside changes in the tobacco and cannabis marketplace.
Their new paper details a longitudinal pilot project exploring the momentary and long-term links between cannabis use, postpartum depression, and early parenting.
Randomized trial finds distinct immune biomarker changes in light vs. heavy drinkers, highlighting dose- and behavior-dependent effects of alcohol on inflammation.
Abby Morales, Kevin McCurdy, and Jacob Talamantes represented CADRE at this year’s Emerging Areas of Science IDeA Symposium in Providence, RI, presenting cutting-edge research on alcohol use disorder and related health outcomes.
Former CADRE Investigator, Carolina Haass-Koffler, collaborates with Brown University engineers to pioneer groundbreaking diagnostic tools that detect opioid exposure in adults and newborns.
CADRE supported researchers have launched a study testing MDMA, known as ecstasy or molly, and talk therapy as a treatment for PTSD and alcohol use disorder in military veterans.
CADRE is currently accepting applications for Research Project Lead. Support of up to $200,000 will be provided. Intent submissions are due by Friday, June 13, 2025.
CADRE is currently accepting applications for Pilot Project Lead. Support of up to $75,000 will be provided. Intent submissions are due by Monday, March 31, 2025.
In a Q&A, Peter Monti, a professor of alcohol and addiction studies at Brown University and a leading researcher of alcohol and disease exacerbation, shared his perspective on alcohol and cancer.
With renewed funding from the National Institutes of Health, the Center for Addiction and Disease Risk Exacerbation will build on its research to understand mechanisms linking substance use with chronic disease.
A team of Brown faculty members is conducting the first study of its kind to investigate whether MDMA-assisted therapy can relieve the suffering of Veterans with PTSD and alcohol use disorder.
Post traumatic stress disorder (PTSD) is among the most common conditions facing U.S. Veterans, with no effective cure. Additionally, many Veterans use alcohol to alleviate their trauma, making medical treatment even more complex. For these high risk patients, Professors Christy Capone and Carolina Haass-Koffler are thinking outside the box: Could a treatment involving psychedelic drugs potentially save Veteran lives?